StonvexLoading…
StonvexStonvexStonvexCore line items from SPT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $121.50M | $457.55M | $336.66M | $221.07M |
Operating Income | $-5.85M | $-43.45M | $-32.63M | $-23.52M |
Net Income | $-6.34M | $-43.33M | $-32.59M | $-23.20M |
EPS (Diluted) | $-0.11 | $-0.74 | $-0.56 | $-0.40 |
Total Assets | $508.60M | $523.06M | $481.40M | $422.93M |
Total Liabilities | $293.41M | $319.64M | $287.27M | $238.38M |
Cash & Equivalents | $111.62M | $95.27M | $90.64M | $101.53M |
Free Cash Flow OCF − CapEx | $24.12M | $39.32M | $29.44M | $20.93M |
Shares Outstanding | 59.74M | 58.63M | 58.40M | 58.13M |